Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | NUVL | CYTK | ||
| Company | Halozyme Therapeutic | Nuvalent Inc Cl A | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.03 | 83.49 | 46.85 | ||
| High | 48.21 | 87.32 | 50.32 | ||
| Low | 46.88 | 82.81 | 46.85 | ||
| Last | 46.96 | 84.22 | 48.87 | ||
| Change | -0.36 | -0.42 | +2.13 | ||
| % Change | -0.76% | -0.50% | +4.56% | ||
| Volume | 4,794,800 | 1,114,200 | 3,805,200 | ||
| 20-Day Average Volume | 1,653,865 | 432,720 | 1,230,010 | ||
| Previous Close | 47.32 | 84.64 | 46.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 48.12 | 91.68 | 49.94 | ||
| 20-Day Raw Stochastic | 19.79% | 17.53% | 44.71% | ||
| 20-Day Relative Strength | 41.86% | 37.26% | 44.49% | ||
| Weighted Alpha | +24.06 | +6.81 | -31.51 | ||
| Today's Opinion | 72% Sell | 8% Buy | 100% Sell | ||
| Previous Opinion | 72% Sell | 8% Buy | 100% Sell | ||
| Last Month's Opinion | 40% Sell | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.17% since 12/13/24 | -3.04% since 12/13/24 | +0.45% since 12/13/24 | ||
| Low | 46.45 on 12/18/24 | 81.36 on 12/19/24 | 45.66 on 12/19/24 | ||
| High | 49.60 on 12/18/24 | 89.31 on 12/17/24 | 50.32 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | +2.62% since 11/20/24 | -7.62% since 11/20/24 | -1.99% since 11/20/24 | ||
| Low | 44.80 on 11/21/24 | 81.36 on 12/19/24 | 45.66 on 12/19/24 | ||
| High | 50.00 on 11/25/24 | 97.65 on 11/25/24 | 52.84 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | -20.73% since 09/20/24 | -22.02% since 09/20/24 | -9.11% since 09/20/24 | ||
| Low | 42.01 on 11/18/24 | 81.36 on 12/19/24 | 45.66 on 12/19/24 | ||
| High | 62.13 on 11/11/24 | 108.50 on 09/23/24 | 59.39 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | -7.67% since 06/20/24 | +7.42% since 06/20/24 | -5.69% since 06/20/24 | ||
| Low | 42.01 on 11/18/24 | 64.67 on 08/08/24 | 45.66 on 12/19/24 | ||
| High | 65.53 on 08/29/24 | 113.51 on 09/16/24 | 61.38 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,974,580 | 5,984,084 | 5,767,344 | ||
| Shares Outstanding, K | 127,227 | 71,053 | 118,014 | ||
| Annual Sales | 829,250,000 | 0 | 7,530,000 | ||
| Annual Net Income | 281,590,000 | -126,220,000 | -526,240,000 | ||
| Last Quarter Sales | 290,080,000 | 0 | 460,000 | ||
| Last Quarter Net Income | 137,010,000 | -84,350,000 | -160,550,000 | ||
| 60-Month Beta | 1.23 | 1.31 | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.27 on 10/31/24 | -1.28 on 11/12/24 | -1.36 on 11/06/24 | ||
| Latest Earnings Date | 10/31/24 | 11/12/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 13.60 | 0.00 | 0.00 | ||